Agenus to Present New Clinical Data on AGEN1181 at AACR 2021
Clinical benefit in previously unresponsive tumors, including CRC, ovarian, and endometrialConfirmed responses in cold tumors as characterized by MSSNo neuroendocrine...
Clinical benefit in previously unresponsive tumors, including CRC, ovarian, and endometrialConfirmed responses in cold tumors as characterized by MSSNo neuroendocrine...
~ Presentation to highlight the potential of Gennao’s proprietary, non-viral gene monoclonal antibody (GMAB) platform technology to systemically deliver immunostimulatory...
CRANBURY, N.J., March 10, 2021 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery...
CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused...
MONTREAL, March 10, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the...
Additional preclinical data on ZN-c3 and the Company’s EGFR inhibitor, ZN-e4, will be presented as poster presentationsNEW YORK and SAN...
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 10, 2021 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical...
SOUTH SAN FRANCISCO, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused...
RLY-4008 demonstrates strong activity against known clinical on-target resistance mutations in cellular and in vivo preclinical modelsCAMBRIDGE, Mass., March 10,...
Additional preclinical data on ZN-c3 and the Company’s EGFR inhibitor, ZN-e4, will be presented as poster presentationsNEW YORK and SAN...
Tumor model data shows potential of CCR4 antagonist to alter immunosuppressive tumor microenvironment to improve CAR T-cell therapy in solid...
RLY-4008 demonstrates strong activity against known clinical on-target resistance mutations in cellular and in vivo preclinical modelsCAMBRIDGE, Mass., March 10,...
CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering...
PALO ALTO, Calif.--(BUSINESS WIRE)--GigCapital2, Inc. (“GigCapital2”) (NYSE: GIX), a Technology, Media and Telecom (TMT) Private-to-Public Equity (PPE)™ corporation, today announced...
Acquisition helps boost hemp ecosystem growth plan to maximize benefits of hemp on planet SANTA FE, N.M. & LONGMONT, Colo.--(BUSINESS...
Vancouver, British Columbia--(Newsfile Corp. - March 10, 2021) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company"),...
PALO ALTO, Calif.--(BUSINESS WIRE)--GigCapital2, Inc. (“GigCapital2”) (NYSE: GIX), a Technology, Media and Telecom (TMT) Private-to-Public Equity (PPE)™ corporation, today announced...
LOS ANGELES--(BUSINESS WIRE)--Exym, a leader in EHR software for behavioral health serving agencies across California, announced the launch of their...
Acquisition helps boost hemp ecosystem growth plan to maximize benefits of hemp on planet SANTA FE, N.M. & LONGMONT, Colo.--(BUSINESS...
Leading Community Health System Implements Kyruus ProviderMatch® to Expand Healthcare Access, Enhance Patient-Provider Matching BOSTON--(BUSINESS WIRE)--Kyruus, the leader in provider...